Although few studies have examined the SMI of CD patients according to sex, one study defined sarcopenia in terms of the SMI (i.e., low SMI in this study) and reported that the frequency was 56.4% for males and 81.4% for females with CD21. Here, CR2 is linked to sarcopenia.